Cbd of Denver Inc
CBD of Denver Inc. engages in developing and commercializing cannabidiol (CBD) products. It is involved in the research, development, and distribution of premium hemp extract products. The company was formerly known as Verde Media Group, Inc. and changed its name to CBD of Denver Inc. in 2018. CBD of Denver Inc. is based in Centennial, Colorado. CBD of Denver Inc. operates as a subsidiary of Swis… Read more
Cbd of Denver Inc (CBDD) - Net Assets
Latest net assets as of March 2025: $-1.34 Million USD
Based on the latest financial reports, Cbd of Denver Inc (CBDD) has net assets worth $-1.34 Million USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.52K) and total liabilities ($1.35 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.34 Million |
| % of Total Assets | -15747.95% |
| Annual Growth Rate | N/A |
| 5-Year Change | -267.41% |
| 10-Year Change | N/A |
| Growth Volatility | 358.85 |
Cbd of Denver Inc - Net Assets Trend (2008–2024)
This chart illustrates how Cbd of Denver Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cbd of Denver Inc (2008–2024)
The table below shows the annual net assets of Cbd of Denver Inc from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-1.34 Million | +1.15% |
| 2023-12-31 | $-1.35 Million | +31.33% |
| 2022-12-31 | $-1.97 Million | -895.00% |
| 2021-12-31 | $247.66K | -68.98% |
| 2020-12-31 | $798.37K | +236.43% |
| 2019-12-31 | $-585.18K | +36.57% |
| 2018-12-31 | $-922.51K | +49.24% |
| 2017-12-31 | $-1.82 Million | -16.07% |
| 2015-12-31 | $-1.57 Million | -118100.11% |
| 2013-12-31 | $-1.32K | +99.88% |
| 2010-12-31 | $-1.14 Million | -21.20% |
| 2009-12-31 | $-937.34K | -221.69% |
| 2008-12-31 | $770.25K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cbd of Denver Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 378890900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $79.00K | % |
| Other Comprehensive Income | $-66.98K | % |
| Other Components | $3.76 Million | % |
| Total Equity | $-1.34 Million | 100.00% |
Cbd of Denver Inc Competitors by Market Cap
The table below lists competitors of Cbd of Denver Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Appliqate Inc
PINK:APQT
|
$1.82 |
|
China Energy Recovery Inc
PINK:CGYV
|
$1.82 |
|
Bowmo Inc
PINK:BOMO
|
$1.82 |
|
CHC Group LLC
PINK:CHHCF
|
$1.82 |
|
Cptl Grp Hldngs
PINK:CGHC
|
$1.81 |
|
Homestead Gold and Silver Ltd
PINK:SNLM
|
$1.81 |
|
Ballistic Recovery Systems Inc
PINK:BRSI
|
$1.81 |
|
Cannalink Inc
PINK:CNLK
|
$1.81 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cbd of Denver Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -1,352,006 to -1,336,515, a change of 15,491.
- Net loss of 79,930 reduced equity.
- Other factors increased equity by 95,421.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-79.93K | -5.98% |
| Other Changes | $95.42K | +7.14% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Cbd of Denver Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | $0.00 | $0.00 | x |
| 2009-12-31 | $0.00 | $0.00 | x |
| 2010-12-31 | $0.00 | $0.00 | x |
| 2013-12-31 | $0.00 | $0.00 | x |
| 2015-12-31 | $0.00 | $0.00 | x |
| 2016-12-31 | $0.00 | $0.00 | x |
| 2017-12-31 | $0.00 | $0.00 | x |
| 2018-12-31 | $0.00 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
| 2023-12-31 | $0.00 | $0.00 | x |
| 2024-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cbd of Denver Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.13%
- • Asset Turnover: 92.10x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-11.55%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -164.03% | 0.00% | 0.00x | 2.17x | $-1.32 Million |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.94 Million |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-261.40K |
| 2013 | 0.00% | -1184.28% | 0.28x | 0.00x | $-370.85 |
| 2015 | 0.00% | -5015.86% | 0.10x | 0.00x | $-96.42K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $91.92K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $163.44K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $689.29K |
| 2019 | 0.00% | 1160.98% | 0.51x | 0.00x | $349.67K |
| 2020 | 97.59% | 4.87% | 5.83x | 3.43x | $699.30K |
| 2021 | -95.29% | -1.03% | 11.61x | 7.95x | $-260.77K |
| 2022 | 0.00% | -138.69% | 83.59x | 0.00x | $-3.05 Million |
| 2023 | 0.00% | 19.57% | 23.24x | 0.00x | $718.78K |
| 2024 | 0.00% | -2.13% | 92.10x | 0.00x | $53.72K |
Industry Comparison
This section compares Cbd of Denver Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cbd of Denver Inc (CBDD) | $-1.34 Million | -164.03% | N/A | $1.82 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |